| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
Memorial Sloan-Kettering Cancer Center serves as a 10% Owner at ATNM. Across recent SEC filings that breaks down to 0 buys and 120 sells. Those positions are worth an estimated $3.8M at current prices.
The biggest single holding is ATNM (~$3.8M) as 10% Owner. The recent filings there lean toward selling, a net 992,826 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| May 26, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 40,068 | $1.92 | $77,060.56 | -0.2% | |
| May 25, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 36,400 | $1.90 | $69,235.50 | -0.1% | |
| Apr 26, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 52,577 | $2.04 | $107,265.22 | - | |
| Apr 21, 2016 | ATNM Actinium Pharmaceuticals, Inc. | 10% Owner | Sell | 196,497 | $2.03 | $398,919.43 | -0.2% |